[HTML] nature.com

[HTML][HTML] Challenges in the development of novel therapies, vaccines and siRNAs for the treatment of hypertension

H Nakagami - Hypertension Research, 2023 - nature.com
Hypertension is a common noncommunicable condition estimated to affect over one billion
adults worldwide, with a prevalence that has doubled over the past 20 years [1]. From 2012 …
被引用次数：4 相关文章

[引用][C] Challenges in the development of novel therapies, vaccines and siRNAs for the treatment of hypertension.

H Nakagami - Hypertension Research: Official Journal of the …, 2023 - europepmc.org
Challenges in the development of novel therapies, vaccines and siRNAs for the treatment of
hypertension. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe …

[引用][C] Challenges in the development of novel therapies, vaccines and siRNAs for the treatment of hypertension

H Nakagami - … research: official journal of the Japanese …, 2023 - pubmed.ncbi.nlm.nih.gov
Challenges in the development of novel therapies, vaccines and siRNAs for the treatment of
hypertension Challenges in the development of novel therapies, vaccines and siRNAs for …